Cyxtera Announces Second Quarter 2022 Results
Cyxtera (NASDAQ: CYXT) reported its Q2 2022 financial results, with total revenue reaching $184.1 million, a 4.9% increase year-over-year. Recurring revenue rose to $174.2 million, up 4.1%, while core revenue increased by 5.9% to $168.8 million. The company faced a net loss of $48.1 million and a 3.8% decrease in Transaction Adjusted EBITDA to $60 million, influenced by higher operating costs. Cyxtera’s occupancy stabilized at 74.2%, and it joined the Russell 2000® Index. Despite robust demand, the company revised its EBITDA guidance downward for the year due to FX volatility and supply chain issues.
- Total revenue increased by 4.9% year-over-year to $184.1 million.
- Recurring revenue rose to $174.2 million, a 4.1% increase year-over-year.
- Core revenue grew by 5.9% to $168.8 million.
- Average monthly Core churn decreased to 0.7%, showing improved customer retention.
- Stabilized occupancy at 74.2%, up 580 basis points from Q2 2021.
- Improved net financial leverage at 3.8x, down from 5.6x year-over-year.
- Joined the Russell 2000® Index, enhancing market visibility.
- Net loss of $48.1 million in Q2 2022.
- Transaction Adjusted EBITDA decreased by 3.8% to $60 million.
- Revised EBITDA guidance for the year down by 2.9%, reflecting macroeconomic pressures.
“Our Q2 results, including Cyxtera’s best net bookings quarter to date, completed a strong first half of 2022 and highlights the healthy demand for leading-edge infrastructure solutions,” said
Q2 2022 Financial Highlights
-
Total revenue increased by
, or$8.7 million 4.9% year over year, to in the second quarter.$184.1 million -
Recurring revenue increased by
, or$6.9 million 4.1% year over year, to in the second quarter.$174.2 million -
Core revenue increased by
, or$9.4 million 5.9% year over year, to in the second quarter.$168.8 million -
Net Loss of
in the quarter; Transaction Adjusted EBITDA[1] decreased by$48.1 million , or$2.3 million 3.8% year over year, to in the second quarter, principally due to higher revenue partially offset by higher SG&A.$60.0 million
Business Highlights
-
Average monthly Core churn of
0.7% in the second quarter, a decrease of 30 basis points from the prior quarter. -
Stabilized occupancy of
74.2% at second quarter-end 2022, an increase of 580 basis points from Q2 2021. - Leverage improved year over with Q2 2022 net financial leverage of 3.8x, a decrease from 5.6x as of Q2 2021.
-
Cyxtera joined the Russell 2000® Index in Q2 2022.
“Cyxtera’s team once again delivered strong results as we close out the first half of 2022 with solid momentum,” said
2022 Outlook
2022 Guidance |
|||
($ in millions) |
|
|
|
|
Prior Guidance |
Updated Guidance |
% Change |
Revenue |
|
|
No Change |
Transaction Adjusted EBITDA |
|
|
- |
Maintenance Capital Expenditures |
|
|
No Change |
% of Revenue |
|
|
No Change |
Expansion Capital Expenditures |
|
|
No Change |
Q2 2022 Results Conference Call and Replay Information
The
Investor Presentation and Supplemental Financial Information
Concurrently with holding its conference call,
Upcoming Conferences and Events
-
Deutsche Bank Leveraged Finance Conference -
Raymond James Technology Investors Conference
_________________________________
1 A complete reconciliation of Net Loss to Transaction Adjusted EBITDA is included in the financial tables included in this release. |
About
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the federal securities laws. Forward- looking statements contained in this press release include statements concerning Cyxtera’s estimated financial performance for 2022. Because forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Cyxtera’s control. Actual results and conditions (financial or otherwise) may differ materially from those indicated in the forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results and conditions to differ materially from those indicated in the forward-looking statements, including, but not limited to, the effects of the COVID-19 pandemic on Cyxtera’s business or future results, including supply chain disruptions; increases in interest rates; fluctuations in energy prices; fluctuations in foreign currency exchange rates in the markets in which
Statement Regarding Non-GAAP Financial Measures
This press release contains Transaction Adjusted EBITDA, which is a supplemental measure that is not required by, or presented in accordance with, accounting principles generally accepted in
This press release also includes certain projections of non-GAAP financial measures concerning
Consolidated Balance Sheets (unaudited, in millions, except share information) |
|||||||
|
|
|
|
||||
Assets: |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash |
$ |
39.7 |
|
|
$ |
52.4 |
|
Accounts receivable, net of allowance of |
|
38.5 |
|
|
|
18.3 |
|
Prepaid and other current assets |
|
33.3 |
|
|
|
37.5 |
|
Total current assets |
|
111.5 |
|
|
|
108.2 |
|
|
|
|
|
||||
Property and equipment, net |
|
1,655.7 |
|
|
|
1,530.8 |
|
Operating lease right-of-use assets |
|
260.3 |
|
|
|
— |
|
|
|
755.1 |
|
|
|
761.7 |
|
Intangible assets, net |
|
456.9 |
|
|
|
519.8 |
|
Other assets |
|
17.9 |
|
|
|
16.7 |
|
Total assets |
$ |
3,257.4 |
|
|
$ |
2,937.2 |
|
|
|
|
|
||||
Liabilities and shareholders’ equity: |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
57.8 |
|
|
$ |
57.9 |
|
Accrued expenses |
|
61.9 |
|
|
|
65.3 |
|
Current portion of operating lease liabilities |
|
33.6 |
|
|
|
— |
|
Current portion of long-term debt, finance leases and other financing obligations |
|
51.0 |
|
|
|
50.3 |
|
Deferred revenue |
|
63.3 |
|
|
|
60.7 |
|
Other current liabilities |
|
4.5 |
|
|
|
10.0 |
|
Total current liabilities |
|
272.1 |
|
|
|
244.2 |
|
|
|
|
|
||||
Operating leases liabilities, net of current portion |
|
285.0 |
|
|
|
— |
|
Long-term debt, net of current portion |
|
878.7 |
|
|
|
896.5 |
|
Finance leases and other financing obligations, net of current portion |
|
1,079.4 |
|
|
|
937.8 |
|
Deferred income taxes |
|
32.2 |
|
|
|
29.9 |
|
Warrant liabilities |
|
— |
|
|
|
64.7 |
|
Other liabilities |
|
70.1 |
|
|
|
158.2 |
|
Total liabilities |
|
2,617.5 |
|
|
|
2,331.3 |
|
|
|
|
|
||||
Shareholders’ equity: |
|
|
|
||||
Preferred Stock, |
|
— |
|
|
|
— |
|
Class A common stock, |
|
— |
|
|
|
— |
|
Additional paid-in capital |
|
1,955.5 |
|
|
|
1,816.5 |
|
Accumulated other comprehensive (loss) income |
|
(5.2 |
) |
|
|
10.8 |
|
Accumulated deficit |
|
(1,310.4 |
) |
|
|
(1,221.4 |
) |
Total shareholders’ equity |
|
639.9 |
|
|
|
605.9 |
|
Total liabilities and shareholders’ equity |
$ |
3,257.4 |
|
|
$ |
2,937.2 |
|
Consolidated Statements of Operations (unaudited, in millions, except for share information) |
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Revenues |
$ |
184.1 |
|
|
$ |
175.4 |
|
|
$ |
366.5 |
|
|
$ |
348.3 |
|
Operating costs and expenses |
|
|
|
|
|
|
|
||||||||
Cost of revenues, excluding depreciation and amortization |
|
98.4 |
|
|
|
95.5 |
|
|
|
196.4 |
|
|
|
193.9 |
|
Selling, general and administrative expenses |
|
34.7 |
|
|
|
22.9 |
|
|
|
66.0 |
|
|
|
50.5 |
|
Depreciation and amortization |
|
60.8 |
|
|
|
60.5 |
|
|
|
123.1 |
|
|
|
121.1 |
|
Restructuring, impairment, site closures and related costs |
|
1.3 |
|
|
|
58.9 |
|
|
|
2.6 |
|
|
|
67.0 |
|
Total operating costs and expenses |
|
195.2 |
|
|
|
237.8 |
|
|
|
388.1 |
|
|
|
432.5 |
|
|
|
|
|
|
|
|
|
||||||||
Loss from operations |
|
(11.1 |
) |
|
|
(62.4 |
) |
|
|
(21.6 |
) |
|
|
(84.2 |
) |
Interest expense, net |
|
(38.9 |
) |
|
|
(43.1 |
) |
|
|
(77.5 |
) |
|
|
(86.3 |
) |
Other (expenses) income, net |
|
(0.1 |
) |
|
|
(0.4 |
) |
|
|
0.4 |
|
|
|
(0.9 |
) |
Change in fair value of warrant liabilities |
|
— |
|
|
|
— |
|
|
|
11.8 |
|
|
|
— |
|
Loss from operations before income taxes |
|
(50.1 |
) |
|
|
(105.9 |
) |
|
|
(86.9 |
) |
|
|
(171.4 |
) |
Income tax benefit (expense) |
|
2.0 |
|
|
|
12.9 |
|
|
|
(2.1 |
) |
|
|
25.8 |
|
Net loss |
$ |
(48.1 |
) |
|
$ |
(93.0 |
) |
|
$ |
(89.0 |
) |
|
$ |
(145.6 |
) |
|
|
|
|
|
|
|
|
||||||||
Loss Per Share |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
$ |
(0.27 |
) |
|
$ |
(0.88 |
) |
|
$ |
(0.50 |
) |
|
$ |
(1.34 |
) |
|
|
|
|
|
|
|
|
||||||||
Weighted average number of shares outstanding |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
178,566,352 |
|
|
|
106,100,000 |
|
|
|
176,883,605 |
|
|
|
108,711,200 |
|
Consolidated Statements of Cash Flows (unaudited, in millions) |
|||||||
|
Six Months Ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Net loss |
$ |
(89.0 |
) |
|
$ |
(145.6 |
) |
Cash flows from operating activities: |
|
|
|
||||
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
123.1 |
|
|
|
121.1 |
|
Restructuring, impairment, site closures and related costs |
|
— |
|
|
|
2.0 |
|
Amortization of favorable/unfavorable leasehold interests, net |
|
— |
|
|
|
2.2 |
|
Amortization of debt issuance costs and fees, net |
|
2.0 |
|
|
|
2.7 |
|
Equity-based compensation |
|
9.8 |
|
|
|
3.6 |
|
Reversal of doubtful accounts |
|
(0.4 |
) |
|
|
(0.8 |
) |
Deferred income taxes |
|
3.1 |
|
|
|
(25.8 |
) |
Change of fair value of warrant liabilities |
|
(11.8 |
) |
|
|
— |
|
Non-cash interest expense, net |
|
6.1 |
|
|
|
4.9 |
|
Changes in operating assets and liabilities, excluding impact of acquisitions and dispositions: |
|
|
|
||||
Accounts receivable |
|
(19.8 |
) |
|
|
18.1 |
|
Prepaid and other current assets |
|
4.3 |
|
|
|
2.9 |
|
Other assets |
|
(1.4 |
) |
|
|
(1.0 |
) |
Operating lease right-of-use assets |
|
23.0 |
|
|
|
— |
|
Operating lease liabilities |
|
(26.4 |
) |
|
|
— |
|
Accounts payable |
|
(3.6 |
) |
|
|
(0.8 |
) |
Accrued expenses |
|
(3.5 |
) |
|
|
(15.4 |
) |
Due to affiliates |
|
— |
|
|
|
(22.7 |
) |
Other liabilities |
|
(3.8 |
) |
|
|
60.9 |
|
Net cash provided by operating activities |
|
11.7 |
|
|
|
6.3 |
|
Cash flows from investing activities: |
|
|
|
||||
Purchases of property and equipment |
|
(62.3 |
) |
|
|
(28.1 |
) |
Amounts received from affiliate |
|
— |
|
|
|
117.1 |
|
Net cash (used in) provided by investing activities |
|
(62.3 |
) |
|
|
89.0 |
|
Cash flows from financing activities: |
|
|
|
||||
Proceeds from issuance of long-term debt and other financing obligations |
|
20.0 |
|
|
|
— |
|
Repayment of long-term debt |
|
(42.3 |
) |
|
|
(24.2 |
) |
Repayment of finance leases and other financing obligations |
|
(24.4 |
) |
|
|
(36.2 |
) |
Proceeds from sales leaseback financing |
|
10.0 |
|
|
|
2.4 |
|
Capital redemption |
|
— |
|
|
|
(97.9 |
) |
Proceeds from the exercise of warrants, net of redemptions |
|
1.3 |
|
|
|
— |
|
Proceeds from the exercise of the optional share purchase options |
|
75.0 |
|
|
|
— |
|
Net cash provided by (used in) financing activities |
|
39.6 |
|
|
|
(155.9 |
) |
Effect of foreign currency exchange rates on cash |
|
(1.7 |
) |
|
|
(0.6 |
) |
Net decrease in cash |
|
(12.7 |
) |
|
|
(61.2 |
) |
Cash at beginning of period |
|
52.4 |
|
|
|
120.7 |
|
Cash at end of period |
$ |
39.7 |
|
|
$ |
59.5 |
|
|
|
|
|
||||
Supplemental cash flow information: |
|
|
|
||||
Cash paid for income taxes, net |
$ |
0.2 |
|
|
$ |
4.5 |
|
Cash paid for interest |
$ |
21.9 |
|
|
$ |
33.6 |
|
Non-cash purchases of property and equipment |
$ |
3.5 |
|
|
$ |
8.3 |
|
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (unaudited, in millions) |
|||||||
|
Three Months Ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Net Loss to EBITDA Reconciliation: |
|
|
|
||||
Net loss |
$ |
(48.1 |
) |
|
$ |
(93.0 |
) |
Depreciation and amortization |
|
60.8 |
|
|
|
60.5 |
|
Interest and other expenses, net |
|
39.0 |
|
|
|
43.5 |
|
Income tax benefit |
|
(2.0 |
) |
|
|
(12.9 |
) |
EBITDA |
$ |
49.7 |
|
|
$ |
(1.9 |
) |
Transaction Adjustments |
|
|
|
||||
Equity-based compensation |
|
6.4 |
|
|
|
1.8 |
|
Straight-line rent adjustment |
|
0.5 |
|
|
|
0.7 |
|
Amortization of Favorable / Unfavorable Leasehold Interest & ARO accretion |
|
0.9 |
|
|
|
0.9 |
|
Stand-up separation & other |
|
1.2 |
|
|
|
0.3 |
|
Restructuring costs & other |
|
1.3 |
|
|
|
60.6 |
|
Total Adjustments |
|
10.3 |
|
|
|
64.3 |
|
Transaction Adjusted EBITDA |
$ |
60.0 |
|
|
$ |
62.3 |
|
|
|
|
|
Note: Numbers may not foot or cross-foot due to rounding |
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (unaudited, in millions) |
|||||||
|
Six Months Ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Net Loss to EBITDA Reconciliation: |
|
|
|
||||
Net loss |
$ |
(89.0 |
) |
|
$ |
(145.6 |
) |
Depreciation and amortization |
|
123.1 |
|
|
|
121.1 |
|
Interest and other expenses, net |
|
77.1 |
|
|
|
87.2 |
|
Income tax expense (benefit) |
|
2.1 |
|
|
|
(25.8 |
) |
EBITDA |
$ |
113.3 |
|
|
$ |
36.9 |
|
Transaction Adjustments |
|
|
|
||||
Equity-based compensation |
|
9.8 |
|
|
|
3.6 |
|
Straight-line rent adjustment |
|
1.1 |
|
|
|
1.9 |
|
Amortization of Favorable / Unfavorable Leasehold Interest & ARO accretion |
|
1.8 |
|
|
|
1.7 |
|
Stand-up separation & other |
|
1.8 |
|
|
|
3.4 |
|
Restructuring costs & other |
|
2.6 |
|
|
|
70.9 |
|
Change in fair value of warrant liabilities |
|
(11.8 |
) |
|
|
— |
|
Total Adjustments |
|
5.2 |
|
|
|
81.4 |
|
Transaction Adjusted EBITDA |
$ |
118.5 |
|
|
$ |
118.4 |
|
|
|
|
|
Note: Numbers may not foot or cross-foot due to rounding |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220811005028/en/
Press Contact:
russell.cozart@cyxtera.com
IR Contact:
IR@cyxtera.com
Source:
FAQ
What were Cyxtera's Q2 2022 revenue results?
Did Cyxtera experience any changes in EBITDA for Q2 2022?
What is the current status of Cyxtera's occupancy rate?
What are the key financial highlights from Cyxtera's Q2 2022 report?